Mar. 5 at 4:03 PM
Why I’m not rushing to sell
$INSP right now 👀
Strong Q4 results and continued R&D investments are fueling growth as the company advances its sleep apnea therapy. That’s the kind of execution and reinvestment you want to see if you’re thinking longer term.
Holding steady or trimming?
See the full investment case 👉 https://www.zacks.com/stock/news/2879292/heres-why-you-should-retain-insp-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2879292-teaser-36144&ADID=SYND_STOCKTWITS_TWEET_2_2879292_TEASER_36144